2023-03-28T00:46:25+03:00[Europe/Moscow] en true <p>converting a protein amino acid side from arginine to citrulline </p>, <p>genetically predisposed; environmental </p>, <p>Anti-citrullinated protein antibodies </p>, <p>number of tender joints, global activity of symptoms, ESR</p>, <p>Erythrocyte sedimentation rate</p>, <p>remission</p>, <p>slowing of disease progression &amp; maintaining function</p>, <p>JAK inhibitors &amp; PDE4 inhibitors </p>, <p>methotrexate</p>, <p>AICAR transformylase; adenosine deaminase; inhibit neutrophils</p>, <p>citinib</p>, <p>milast </p>, <p>cAMP</p>, <p>d</p>, <p>d</p>, <p>false; patients do not respond well </p>, <p>prevent inflammatory cytokine signaling by blocking phosphorylation of STAT</p>, <p>Ulcerative colitis, PsA</p>, <p>opportunistic infection &amp; cardiovascular disease</p>, <p>CYP3A4; CYP2C19</p>, <p>a</p>, <p>b</p>, <p>b</p>, <p>a</p> flashcards
Arthritis pt. 1

Arthritis pt. 1

  • converting a protein amino acid side from arginine to citrulline

    What is Citrullination?

  • genetically predisposed; environmental

    Rheumatoid arthritis is considered to occur when ___________ individuals are exposed to specific ___________ risk factors.

  • Anti-citrullinated protein antibodies

    -autoantibodies produced by B-cells that are directed against self-proteins that are citrullinated.

  • number of tender joints, global activity of symptoms, ESR

    What does the Disease Activity Score measure?

  • Erythrocyte sedimentation rate

    -measures the degree of inflammation in the joints by taking out blood and placing it in a small, thin tube and the distance the RBCs settle in one hour is measure. mm/hr

  • remission

    -defined as the absence of signs and symptoms of inflammatory disease activity; or low disease activity as a goal.

  • slowing of disease progression & maintaining function

    The goal(s) for RA patients is what?

  • JAK inhibitors & PDE4 inhibitors

    What are our tsDMARD's?

  • methotrexate

    What is our csDMARD?

  • AICAR transformylase; adenosine deaminase; inhibit neutrophils

    Methotrexate inhibits __________ leading to the accumulation of AICAR. AICAR inhibits ____________. This leads to increased production of adenosine which will ___________.

  • citinib

    How can we tell if a drug is a JAK inhibitor? What suffix?

  • milast

    How can we tell if a drug is PDE4 inhibitor? What suffix

  • cAMP

    Elevated levels of ______ leads to reduction of pro-inflammatory cytokines.

  • d

    Which drug should you carefully weigh the risks & benefits of treating when the patient has depression?

    a) Barcitinib

    b)Tofacitinib

    c) Methotrexate

    d) Apremilast

  • d

    Which drug requires prescribers to monitor weight regularly?

    a) Barcitinib

    b)Tofacitinib

    c) Methotrexate

    d) Apremilast

  • false; patients do not respond well

    When it comes to treating ACPA+ patients, MTX monotherapy is sufficient. True or false?

  • prevent inflammatory cytokine signaling by blocking phosphorylation of STAT

    How do JAK inhibitors work?

  • Ulcerative colitis, PsA

    What are other indications for Tofacitinib (XELJANZ)?

  • opportunistic infection & cardiovascular disease

    What are Box warnings associated with JAK inhibitors?

  • CYP3A4; CYP2C19

    Tofacitnib is metabolized by what enzymes?

  • a

    Which drug is selective for JAK1/JAK2?

    a) Barcitinib

    b)Tofacitinib

    c) Methotrexate

    d) Apremilast

  • b

    Which drug is a Pan-inhibitor (non-selective) JAK?

    a) Barcitinib

    b)Tofacitinib

    c) Methotrexate

    d) Apremilast

  • b

    Which drug was found to increase risk of lung blood clots and had a dose reduction from 10 mg twice daily to 5mg twice daily?

    a) Barcitinib

    b)Tofacitinib

    c) Methotrexate

    d) Apremilast

  • a

    Which drug has been approved as the first systemic treatment of Alopecia?

    a) Barcitinib

    b)Tofacitinib

    c) Methotrexate

    d) Apremilast